Product Reports Resources Pricing Login Book a demo

Cellarity

Biotech & Life Sciences · Cambridge, United States · Founded 2017

Cellarity is a groundbreaking startup that is revolutionizing the process of drug creation. The company operates in the pharmaceutical industry, specifically in the area of drug discovery and development. They serve clients in the healthcare sector, including hospitals, clinics, and other medical institutions. Cellarity's business model is centered around a novel approach to drug discovery. Unlike traditional methods that focus on single molecular targets, Cellarity targets the entire cell, which they believe is a more effective way to treat diseases. This approach is based on a deep understanding of disease biology and leverages advanced technologies like genomics, systems biology, data science, and artificial intelligence (AI). The company's platform provides insights into cellular dysfunction, revealing new biology that can be used to treat a wide range of diseases. This includes diseases that have been overlooked or are too complex to resolve with traditional methods. With ongoing programs in hematology, immuno-oncology, and metabolism, Cellarity is at the forefront of creating a new generation of medicines. Cellarity makes money by developing and selling these innovative drugs. Their interdisciplinary team of experts works together to create these new therapies, which are then sold to healthcare providers. The company's unique approach to drug discovery could potentially lead to more effective treatments for a variety of diseases, making it a promising player in the pharmaceutical industry. Keywords: Drug Creation, Disease Biology, Cellular Dysfunction, Drug Discovery, Genomic Technologies, Systems Biology, Data Science, Artificial Intelligence, Hematology, Immuno-Oncology.

Investors

6 investors on Cellarity's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 4 investors entered at this stage
Flagship Pioneering
BlackRock
The Baupost Group
Pictet
Series B+ 2 investors entered at this stage
Kyowa Kirin
Hanwha Impact

Global footprint

Where Cellarity has talent and traffic

Workforce by country
2 countries with
team presence
🇺🇸 United States97.2%
🇩🇪 Germany2.8%
2 countries shown

Talent graph

The shape of Cellarity's talent

Dealroom maps Cellarity's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

20 team members profilednamed & role-tagged by Dealroom
76 employeestotal headcount
4 executives & foundersidentified by name
DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Cellarity's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about Cellarity

An AI-synthesized read of the highest-engagement posts about Cellarity on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Cellarity on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.